AMANDA BOSTICK: Open Payments
NPI 1023485976 · BEAR, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,964 in 81 payments from 17 companies in 2025. Trend: 2023 $515 · 2024 $1,262 · 2025 $1,964
Food & beverage: $1,879Education: $85
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $436 |
| Gilead Sciences, Inc. | 10 | $338 |
| Novo Nordisk Inc | 15 | $228 |
| Astellas Pharma US Inc | 9 | $213 |
| Lilly USA, LLC | 7 | $153 |
| ABBVIE INC. | 8 | $151 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $142 |
| PFIZER INC. | 3 | $51 |
| Exact Sciences Corporation | 2 | $47 |
| GlaxoSmithKline, LLC. | 3 | $46 |
Products named: AIRSUPRA, BREZTRI, DRIZALMA SPRINKLE, Veozah, Yeztugo, Ozempic, MOUNJARO, FARXIGA.
Industry payments across DE — which companies pay providers there.
